First Reported Case of Hemopericardium Related to Dabigatran Use Reversed by New Antidote Idarucizumab

<div>Computerized tomography (CT) of the chest showing new pericardial effusion and small bilateral pleural effusions with adjacent atelectasis when compared to the CT of the chest performed 21 days priorly.</div>

Case Reports in Cardiology

fig2

Figure 2

Figure 2: First Reported Case of Hemopericardium Related to Dabigatran Use Reversed by New Antidote Idarucizumab 